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ABSTRACT 
We investigated the occurrence, diversity and molecular epidemiology of genes coding for 
acquired AmpC β-lactamases (qAmpC) among clinical isolates of Enterobacteriaceae lacking 
inducible chromosomal AmpCs in Portugal. A total of 675 isolates non-susceptible to broad-
spectrum cephalosporins obtained from four hospitals and three community laboratories 
during a 7-year period (2002-2008) were analysed. The presence of genes coding for qAmpC 
was investigated by phenotypic criteria, polymerase chain reaction (PCR) and sequencing. 
Bacterial identification, antibiotic susceptibility testing, conjugation assays and clonal analysis 
were performed by standard procedures. The presence of bla qAmpC genes was detected in 
50 % (50/100; 41 Klebsiella pneumoniae, 5 Escherichia coli, 4 Klebsiella oxytoca) of the 
presumptive qAmpC producers. DHA-1, detected in those species, was the most prevalent 
qAmpC (94 %, 47/50), being identified since 2003 and throughout the studied period in 
different institutions. Despite the high clonal diversity observed, three DHA-1-producing 
Klebsiella spp. clones were more frequently identified. CMY-2 (6 %, 3/50) was observed in B1-
E. coli clones. Conjugative transfer was only observed in one (2 %) CMY-2-producing isolate. 
Most qAmpC producers (94 %, 47/50) co-expressed SHV-type and/or OXA-1 or CTX-M-32 
extended-spectrum β-lactamases (ESBLs). To the authors' knowledge, this is the first 
description of the molecular epidemiology and the long-term dissemination of qAmpC-
producing Enterobacteriaceae in Portuguese clinical settings, highlighting an evolution towards 
a more complex epidemiological situation regarding cephalosporin resistance in Portugal. 
